Skip to content

MEDICAL INTERNATIONAL TECHNOLOGY INC: 10-Q/A filed 2011-09-02

What MEDICAL INTERNATIONAL TECHNOLOGY INC reported in its quarterly report amendment filed 2011-09-02 (fiscal Q3 2011): 30 published measures, 80 facts as tagged in accession 0001213900-11-004924.

This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.

This filing

Form
10-Q/A (quarterly report amendment)
Filed
2011-09-02
Fiscal period
fiscal Q3 2011
Accession
0001213900-11-004924 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All MEDICAL INTERNATIONAL TECHNOLOGY INC filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2011-06-30877,954USD
At 2010-09-30668,164USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2011-06-301,576,247USD
At 2010-09-301,569,079USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2011-06-3052,193USD
At 2010-09-3026,716USD
At 2010-06-30109,892USD
At 2009-09-3077,461USD

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2010-10-01 to 2011-06-30-444,057USD273
2009-10-01 to 2010-06-302,689,010USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2010-10-01 to 2011-06-30588,923USD273
2009-10-01 to 2010-06-30-3,061,970USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2010-10-01 to 2011-06-30-108,204USD273
2009-10-01 to 2010-06-30-20,606USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2011-06-30-12,754,057USD
At 2010-09-30-12,418,732USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2011-04-01 to 2011-06-3071,478,627shares91
2010-10-01 to 2011-06-3071,478,627shares273
2010-04-01 to 2010-06-3062,297,795shares91
2009-10-01 to 2010-06-3062,297,795shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2011-04-01 to 2011-06-30-0.003USD/shares91
2010-10-01 to 2011-06-30-0.004USD/shares273
2010-04-01 to 2010-06-30-0.001USD/shares91
2009-10-01 to 2010-06-30-0.01USD/shares273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2011-06-30117,306USD
At 2010-09-3020,948USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2011-04-01 to 2011-06-30-378,249USD91
2010-10-01 to 2011-06-30-440,646USD273
2010-04-01 to 2010-06-30-69,070USD91
2009-10-01 to 2010-06-30-688,214USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2011-06-30468,017USD
At 2010-09-30283,948USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2011-06-301,510,599USD
At 2010-09-301,569,079USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2011-04-01 to 2011-06-30433,588USD91
2010-10-01 to 2011-06-30631,234USD273
2010-04-01 to 2010-06-30165,451USD91
2009-10-01 to 2010-06-301,039,136USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2011-06-30360,217USD
At 2010-09-30224,223USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2011-04-01 to 2011-06-3055,339USD91
2010-10-01 to 2011-06-30190,588USD273
2010-04-01 to 2010-06-3096,381USD91
2009-10-01 to 2010-06-30350,922USD273

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2011-04-01 to 2011-06-30433,588USD91
2010-10-01 to 2011-06-30631,234USD273
2010-04-01 to 2010-06-30100,257USD91
2009-10-01 to 2010-06-30897,458USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2011-04-01 to 2011-06-300USD91
2010-10-01 to 2011-06-300USD273
2010-04-01 to 2010-06-3065,194USD91
2009-10-01 to 2010-06-30141,678USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2011-06-3071,478,627shares
At 2010-09-3066,260,295shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2011-06-3012,454,085USD
At 2010-09-3011,931,996USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2011-06-30-405,440USD
At 2010-09-30-420,805USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2011-06-30-698,294USD
At 2010-09-30-900,915USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2011-06-30602,356USD
At 2010-09-30472,727USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2011-06-30485,051USD
At 2010-09-30451,779USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2011-04-01 to 2011-06-30-463,864USD91
2010-10-01 to 2011-06-30-554,315USD273
2010-04-01 to 2010-06-30-89,506USD91
2009-10-01 to 2010-06-30-765,203USD273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2010-10-01 to 2011-06-3027,232USD273
2009-10-01 to 2010-06-3016,456USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2011-04-01 to 2011-06-30-85,615USD91
2010-10-01 to 2011-06-30-113,669USD273
2010-04-01 to 2010-06-30-20,436USD91
2009-10-01 to 2010-06-30-76,989USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2010-10-01 to 2011-06-30491,581USD273
2009-10-01 to 2010-06-30100,000USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2010-10-01 to 2011-06-30-3,586USD273
2009-10-01 to 2010-06-30-6,535USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2010-10-01 to 2011-06-30-135,994USD273
2009-10-01 to 2010-06-30-16,529USD273

Inspect the source

Entity
MEDICAL INTERNATIONAL TECHNOLOGY INC / CIK 0001112372
Captured
SEC response SHA-256
583e16457474994aef1257463e60713733dd0fb17cace039913f590f301e8b97

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001112372.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))